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Di Giulio I, St George RJ, Kalliolia E, Peters AL, Limousin P,
Day BL. Maintaining balance against force perturbations: impaired
mechanisms unresponsive to levodopa in Parkinson’s disease. J Neu-
rophysiol 116: 493–502, 2016. First published April 20, 2016;
doi:10.1152/jn.00996.2015.—There is evidence that postural instabil-
ity associated with Parkinson’s disease (PD) is not adequately im-
proved by levodopa, implying involvement of nondopaminergic path-
ways. However, the mechanisms contributing to postural instability
have yet to be fully identified and tested for their levodopa respon-
siveness. In this report we investigate balance processes that resist
external forces to the body when standing. These include in-place
responses and the transition to protective stepping. Forward and
backward shoulder pulls were delivered using two force-feedback-
controlled motors and were randomized for direction, magnitude, and
onset. Sixteen patients with PD were tested OFF and ON levodopa,
and 16 healthy controls were tested twice. Response behavior was
quantified from 3-dimensional ground reaction forces and kinematic
measurements of body segments and total body center-of-mass (CoM)
motion. In-place responses resisting the pull were significantly smaller
in PD as reflected in reduced horizontal anteroposterior ground
reaction force and increased CoM displacement. Ankle, knee, and hip
moments contributing to this resistance were smaller in PD, with the
knee extensor moment to backward pulls being the most affected.
The threshold force needed to evoke a step was also smaller for PD in
the forward direction. Protective steps evoked by suprathreshold pulls
showed deficits in PD in the backward direction, with steps being
shorter and more steps being required to arrest the body. Levodopa
administration had no significant effect on either in-place or protective
stepping deficits. We conclude that processes employed to maintain
balance in the face of external forces show impairment in PD consis-
tent with disruption to nondopaminergic systems.
Parkinson’s disease; balance; postural instability; dopaminergic path-
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NEW & NOTEWORTHY
We introduce a new method to investigate postural insta-
bility in Parkinson’s disease (PD) using computer-con-
trolled motors to deliver precise pulls to the shoulders of
subjects while standing. It mimics the clinical pull test but
uses forces with unpredictable timing, direction, and mag-
nitude. It revealed a number of balance control deficits in
PD. Notably, the identified deficits were not significantly
altered by levodopa medication, suggesting that disruption
to nondopaminergic systems contributes to postural insta-
bility in PD.
THE POSTURAL INSTABILITY associated with Parkinson’s disease
(PD) can have serious consequences because it is linked with
falls (Balash et al. 2005; Burn 2002; Frenklach et al. 2009;
Schrag et al. 2015), increased morbidity, and increased mor-
tality (Hely et al. 2005). It poses a difficult challenge for
clinicians because postural instability becomes more prevalent
with disease progression (Kim et al. 2013; Viitasalo et al.
2002) while at the same time becoming relatively less respon-
sive to levodopa (Koller et al. 1989; Steiger et al. 1996). This
has led to the suggestion that disruption of nondopaminergic
pathways may play a key role in the evolution of postural
instability in PD (Bonnet et al. 1987; Muller et al. 2013;
Pahapill and Lozano 2000; Schrag et al. 2015; Viitasalo et al.
2002; Zweig et al. 1989). If true, this would have important
implications for therapeutic strategies aimed at alleviating the
problem. However, postural instability is a broad phenomenon
presumably stemming from different pathophysiological pro-
cesses. These have yet to be fully identified and quantified,
arguably a necessary requirement for critical examination of
the nondopaminergic hypothesis. In this study we investigated
this hypothesis with respect to the mechanisms that act to
preserve balance when an external force perturbs the body.
Maintaining balance in the face of an external force can
involve three processes. The first process is responsible for
generating forces between the feet and the floor to counteract
the perturbing force and decelerate body motion. During the
execution of this “in-place” response, a second process as-
sesses the current body state to establish whether the body is
falling or is likely to fall in the near future. If this threshold is
crossed, then a third process is engaged that is responsible for
executing a step with the appropriate metrics to alter the base
of support and recapture the falling body. This cycle is then
repeated until the body is in equilibrium. To our knowledge,
impairments within each of these processes and their depen-
dence on dopaminergic pathways have not been studied under
identical conditions in the same sample of patients. Most other
studies in this field have been quite diverse with respect to the
types of postural perturbations employed and the evoked be-
havioral responses measured. Perturbations have consisted of
platform translations (de Kam et al. 2014; Dimitrova et al.
2004; Horak et al. 1992, 1996; Jacobs and Horak 2006; King
et al. 2010; Lee et al. 2013; Smulders et al. 2014), platform
rotations (Bloem et al. 1996; Carpenter et al. 2004, Oude
Nijhuis et al. 2014; Schieppati and Nardone 1991), or pulls to
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the body (Foreman et al. 2012; Jöbges et al. 2004; McVey et al.
2013). These perturbations have been employed to elicit pos-
tural in-place responses (Bloem et al. 1996; Carpenter et al.
2004; Horak et al. 1992, 1996; Oude Nijhuis et al. 2014;
Schieppati and Nardone 1991), step responses (de Kam et al.
2014; Foreman et al. 2012; Jacobs and Horak 2006; Jöbges et
al. 2004; King et al. 2010; Lee et al. 2013; McVey et al. 2013;
Smulders et al. 2014), or both (Dimitrova et al. 2004). Some of
these studies have investigated the effects of levodopa, but
these have been distributed between different perturbation
types and different behavioral responses (Bloem et al. 1996;
Carpenter et al. 2004; de Kam et al. 2014; Foreman et al. 2012;
Horak et al. 1992, 1996; Jacobs and Horak 2006; King et al.
2010).
Our aims were to investigate, in a single sample of PD
patients, impairments of each of the three balance processes
that are used to resist external forces and to establish the
levodopa responsiveness of the identified impairments. To
achieve this, we employed a laboratory version of the clinical
pull test. The clinical pull test, which is used as part of the
motor examination within the Unified Parkinson’s Disease
Rating Score (UPDRS), requires that the patient is pulled
backward by the clinician with sufficient force to evoke one or
more steps to prevent a fall. However, this clinical test suffers
from a number of weaknesses, including uncontrolled force
profiles, highly predictable perturbation timing and direction,
and coarse scoring of performance. Above all, it only assesses
the recovery process once a loss of balance has occurred; it
does not address the ability to resist the perturbing force in the
first place. Our laboratory version of the pull test circumvents
these drawbacks by using computer-controlled motors to de-
liver precise forward and backward perturbing forces. This
allows the delivery of balance-threatening perturbations that
are unpredictable in their timing, amplitude, and direction. By
measuring whole body kinematic responses and ground reac-
tion forces, we are able to replace the discrete clinical scoring
system with continuous measures of performance. By varying
the magnitudes of the pull tailored to each individual, we are
able to isolate the three processes of external force resistance
that are employed to maintain standing balance. These consti-
tute 1) the first line of defense of generating resistance without
moving the feet, i.e., in-place response; 2) the decision to adopt
a stepping strategy, i.e., stepping threshold; and 3) the execu-
tion of steps as a second line of defense to recover balance, i.e.,
stepping response. We have determined which aspects of these
behaviors are impaired in patients with PD by comparing them
with age-matched controls. We investigated whether these
impairments are dependent on dopaminergic pathways by mea-
suring the quantitative effects of levodopa administration.
METHODS
Ethics
Procedures were approved by the University College London
Hospitals National Health Service Trust ethics committee. Partici-
pants gave written, informed consent to the experiment, which con-
formed to the Declaration of Helsinki.
Participants and Clinical Rating
Sixteen patients with PD patients (4 women; age, 66.8  6.5 yr;
height, 1.69  0.11 m; weight, 77.9  14.3 kg, means  SD) were
recruited from the National Hospital for Neurology and Neurosurgery.
The patients had a mean disease duration of 8.3  6.9 yr, were at
Hoehn and Yahr stages 2 to 3, were not implanted with deep brain
stimulators, and had not fallen during the 6-mo period prior to testing.
Additional patient details are given in Table 1. Sixteen healthy
participants (7 women; age, 65.2  8.6 yr; height, 1.70  0.09 m;
weight, 74.6  11.8 kg) with no balance or self-reported neurological
problems were recruited as controls. Each patient was assessed by an
experienced clinician using the part III UPDRS test (motor score). The
scoring was undertaken during each experimental session and subse-
quently checked by the same clinician using video recordings of the
test. All participants performed two sessions during a single visit to
the laboratory. The PD group was tested first in the OFF state, i.e.,
after at least 12 h of medication (levodopa) washout, and later in the
ON state, i.e., 1 h after taking their equivalent morning dose. Healthy
individuals were also tested twice to control for fatigue and/or learn-
ing effects. The limitation of this approach is that it assumes any such
time-dependent effects are similar for both groups.
Table 1. Patient details
Patient Identifier Age, yr Disease Duration, yr Height, m Weight, kg
Hoen and Yahr
Stage
UPDRS III
LED,
mg/day ComorbidityOFF ON
PTP01 71.1 21 1.67 70 2 28 15 450 None
PTP02 78.2 4 1.7 74.3 3 40 29 650 L knee replacement
PTP03 71.9 5 1.71 102 2 59 38 800 Prostate cancer
PTP04 68.2 6 1.75 78.9 2 20 13 530 None
PTP05 67.7 20 1.55 63.3 2 64 45 850 Lower back pain
PTP06 69.8 20 1.68 62.8 2.5 29 19 1,604 Carotid stenosis, elbow surgery
PTP07 72.1 2 1.54 80.6 2 36 33 150 None
PTP08 74.8 1 1.45 79.8 2 33 24 150 Arthritis, L&R knee replacement,
angina
PTP09 62.4 8 1.79 77.9 2 40 26 550 Lower back pain
PTP10 65.8 15 1.64 79.7 2.5 47 27 2,096 Cerebrovascular problems
PTP11 55.6 10 1.78 65.5 2 43 36 1,025 Knee and lower back pain
PTP12 63.4 2 1.76 83 2 40 31 300 Migraine
PTP13 63.9 5 1.61 52 2 40 32 680 None
PTP14 77.8 3 1.74 77 2 34 19 490 None
PTP15 63.6 6 1.86 91.1 2 24 12 750 None
PTP16 58.6 5 1.79 108.5 2 30 24 310 Impulse control disorder
LED, levodopa equivalent dose (Tomlinson et al. 2010). Only PTP02 used assistive devices for walking.
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Experimental Procedure
Participants stood symmetrically in a comfortable position with
their feet on separate force plates. The feet positions were marked
with chalk to ensure repeatability. Light, inextensible kite strings
(Climax Protec 50daN; Ockert, Puchheim, Germany) were connected
bilaterally to the anterior and posterior shoulder straps of a full body
harness worn by the participant. The harness was also connected to an
overhead zip wire, which could arrest a fall but allowed forward and
backward steps. A randomized series of anterior and posterior pulls of
variable force were delivered via the strings by two motors (Fig. 1),
one positioned in front and the other behind at a distance of 2.7 m
from the participant. In contrast to the clinical pull test, forward and
backward pulls were intermixed to minimize expectation of pull
direction and to investigate further the reported greater instability in
the backward direction in PD (Carpenter et al. 2004; Lee et al. 2013).
The participant’s center of pressure (CoP) was calculated and
monitored in real time using the eight vertical force signals from the
two force plates (4 from each plate under each foot). Before each
perturbation trial, real-time CoP was used to ensure the participant
was in a stable state as judged qualitatively by CoP oscillations not
being excessively high. It was also used to check that their weight
distribution was not overly deviated from their preferred position.
Their preferred position was measured at the beginning of each
session while they stood for 30 s in a comfortable position with a
small tensioning force (2 N) applied to the pulling strings (zero net
force). The perturbation trial was not initiated and the participant’s
position or posture was corrected if their CoP had deviated from this
preferred position by more than 30 mm forward, 25 mm backward, or
50% of the distance laterally to either foot.
At a random time (2–5 s) before trial onset, the small bidirectional
tensioning force (2 N) was applied to the strings. The participants
were warned before this occurred and were told that a variable-sized
pull would subsequently be delivered in an unpredictable direction a
short time later. Participants were instructed to resist the pull without
moving their feet unless one or more steps became necessary to avoid
a fall, in which case they were asked to try to become stationary as
soon as balance was regained. Each trial lasted 7 s and consisted of 2-s
pre-pull, 1-s pull (0.1-s ramp to plateau for 0.9-s duration), and 4-s
post-pull.
Each session was divided into seven blocks of eight trials each.
After each block, the participant was allowed to move about or sit
down. For the first block, four fixed pulls of 10 and 20 N in each
direction were applied twice in random order to probe the partici-
pant’s stability. For each subsequent block, four other pulls of variable
magnitude (range from 10.5 to 60 N across all participants and
conditions), which often induced steps, were randomly intermixed
with the four fixed pulls. The fixed pulls of 10 and 20 N were used to
assess the participant’s in-place responses, whereas the variable mag-
nitude pulls were used to assess stepping threshold as well as stepping
response behavior.
Threshold determination. To minimize the test duration, a method
was devised that attempted to converge on a participant’s stepping
threshold, i.e., the pull force that evoked a stepping response 50% of
the time, within 12–16 trials per direction. A hybrid method was used
that combined a human estimator with a machine algorithm. The
human estimator, who was experienced in observing PD patients
responding to pulls, provided the initial “best guess” at the pull level
that was likely to be above, but close to, a participant’s threshold
without subjecting him or her to excessive force. Once steps had been
evoked, the machine algorithm was used to help and converge on the
threshold. After each trial, the operator inserted the outcome (Step or
No Step) in custom-built software (LabVIEW; National Instruments,
Austin, Texas) that estimated the stepping threshold and selected
future pull forces to refine the estimate. However, the operator
always reserved the right to intervene and set the forces manually
at the beginning of each block if the estimate was deemed to
require fine-tuning. If the threshold estimation was not very accu-
rate (SD 1 N) at the end of the 56 pulls, or if the outcome was
unclear for a particular pull level, extra targeted pulls (usually no
more than 4 in total) were added to resolve the uncertainty.
Apparatus and Measurements
The pulls were generated by two servomotors (AKM52H-
ANCNAA00; Kollmorgen, Radford, VA) running in torque mode and
controlled through custom-built LabVIEW software. The motors were
tuned to deliver a demanded torque regardless of the participants’
movements. Two custom-built strain-gauge force transducers (sup-
ported from strings hanging from the ceiling) were placed in series
with the kite strings and used to measure the horizontal force admin-
istered during each pull (Fig. 1). The three components of ground
reaction force and the point of application of the net force vector
under each foot was measured using two force plates (models 9281B
and 9287; Kistler Instrumente, Winterthur, Switzerland). Forces were
sampled at 1 kHz and later downsampled to 100 Hz.
Whole body kinematics were recorded in three dimensions using an
active infrared motion capture system (CODA CX1; Charnwood
Dynamics, Rothley, UK). Clusters of four infrared-emitting diodes
(IRED) were placed on the following segments: feet, shanks, thighs,
pelvis, upper back, head, lower arms, and upper arms. A pointer was
used to associate the clusters with the following anatomical land-
marks: 5th and 1st metatarsal heads, 2nd toe tip, heels, lateral and
medial malleoli, lateral and medial femoral epicondyles, greater
trochanters, lateral upper edges of the pelvis, navel, clavicle notch,
acromions, anterior and posterior aspects of the shoulders, ulnar and
radial elbows, ulnar and radial wrists, 12th thoracic vertebra, 7th
cervical vertebra, ear meatus, lateral orbital edges of the zygomatic
bone, and top of the head. Each cluster’s position was marked with
washable pen, and landmarks were marked with adhesive stickers to
control for cluster movement and artifacts between blocks and ses-
sions. If any cluster was inadvertently moved, the landmarks relative
to the cluster were repointed. Kinematic data were sampled at 100 Hz.
Data Analysis
The motion capture files were imported into Visual 3D (C-Motion;
Germantown, MD), and a whole body model was built. The marker
trajectories were filtered with a Butterworth zero-lag, low-pass, 12-Hz
filter. The segments comprising feet, shanks, thighs, pelvis, torso,
head, lower arms, and upper arms were defined for the model. The
participant’s height and weight were specified to calculate whole body
center of mass (CoM). The CoM of the model was obtained from the
Fig. 1. Apparatus. Participants stood on two force platforms and wore a safety
harness. Two motors delivered 1-s-long pulls of different force and direction
(backward and forward) via kite strings attached at shoulder level. Participants
were asked to resist the pull unless one or more steps became necessary to
maintain balance.
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calculated center of mass of the kinetic segments resolved in the
laboratory coordinate system. The center of mass of each segment was
calculated using the Demter and Hanavan’s model, with each limb
segment modeled as a conical frustrum, the pelvis and thorax modeled
as elliptical cylinders, and the head modeled as an ellipsoid. Ankle,
knee, and hip internal moments were calculated, and these data
together with the kinematic model calculations, including landmark
locations and joint angles calculated between segments, were exported
into Matlab (The MathWorks, Natick, MA).
Trials were divided into Step and No-Step trials offline. The criteria
for a Step trial were that 1) the vertical ground reaction force signal
from one force platform dropped below 5 N, and 2) the corresponding
foot moved in the direction of the pull. This defined the initial foot-lift
event. Foot landing was identified using a hybrid method. If the foot
landed on the force platform, landing time was the frame after foot lift
in which the vertical signal first rose above 5 N. If foot events
occurred off the force plate, the following kinematic method was used
(adapted from Pijnappels et al. 2001). A rigid foot segment was built
from landmarks comprising 2nd toe tip, 1st and 5th metatarsal head,
heel, and medial and lateral malleoli. Foot landing was defined as the
frame after foot lift (5 frames) when the foot segment anteroposte-
rior (AP) velocity dropped below the mean plus 1.5 times the SD of
the pre-pull value for more than 3 frames. When the force and
kinematic methods were both available, they yielded a maximum
discrepancy of 2 frames.
Further steps were identified with the extra constraint that the
stepping foot had to move past the stance foot in the direction of the
pull to exclude foot movements that were not directly involved in
arresting body motion. For these steps, foot lift was defined as the first
frame in which a foot segment’s AP velocity and AP position both
exceeded the mean values plus 1.5 times the SD of the previous stance
phase for more than 3 frames.
Initial posture. Mean lower, upper, and overall body configurations
were measured between 1 and 0.5 s before pull onset (after the strings
were tensioned). Although participants were in a state of readiness for
the upcoming pull, they did not know its size or direction. Ankle joint,
hip joint, and sagittal plane trunk segment angles were calculated from
orientations in space of appropriate IRED clusters. As a global
measure, the position of the CoP was measured relative to the mean
ankle location (midpoint between the left and right ankle joint
centers).
In-place responses. Pull forces of 10 and 20 N were used to
measure in-place responses, but trials were excluded if a step oc-
curred. Resisting force was calculated as the mean anteroposterior
(AP) horizontal ground reaction force (summed from the 2 force
plates) measured between pull onset and 0.5 s later. CoM displace-
ment was measured as displacement in the AP direction at the end of
the 1-s pull relative to its mean pre-pull position (from 150 to 50
ms), normalized by the participant’s body mass. For each joint, the left
and right moments in the sagittal plane were averaged after subtrac-
tion of the pre-pull baseline to remove any offset. The mean value
between pull onset and 0.5 s later was calculated and normalized by
the pull force to allow the responses to the two pull levels to be
combined.
Stepping threshold. Stepping threshold was estimated from all the
trials and defined as the pull force that induced a step 50% of the time.
This quantity was calculated by first fitting a sigmoid curve to the pull
force vs. step outcome graph (see Fig. 4A), differentiating the curve,
and measuring the force at which its peak occurred. This value was
then normalized by dividing by the participant’s body mass. The
rationale for this normalization was based on the results of a stepwise
multilinear regression analysis in which sex, age, height, body mass,
and height  body mass were included as potential predictors of
threshold. The results suggested that body mass is the main factor
consistently influencing threshold.
Stepping responses. Foot-lift latency was the time relative to pull
onset when the vertical ground reaction force signal dropped below 5
N. Momentum at foot lift was determined as the AP velocity of the
CoM at foot-lift onset multiplied by the participant’s body mass. Step
length was defined as the foot displacement with respect to the hip and
was measured as the difference in the AP position of the foot’s leading
edge (2nd toe tip for forward pulls and heel for backward pulls)
between first foot-lift and first foot-landing times minus the difference
in the hip AP position at the same time points. Number of steps was
limited to three, because an operator often intervened when more steps
occurred.
Statistical Analysis
Statistical analysis was performed using Statistica (Dell Statistica
12; Tulsa, OK). A Wilcoxon test was used to assess the difference
between OFF- and ON levodopa for the UPDRS scores. A general
linear model repeated measure (GLMRM) design was used to analyze
the other quantities, but with data for forward and backward pulls
being analyzed separately. This separation of direction was because
the pull forces for evoking steps were higher in the forward than the
backward direction [direction: F(1,30)  10.72, P  0.003]. For
in-place responses, pull size (10 and 20 N) and session (1 and 2) were
fixed factors, and group (PD and healthy controls) was the between-
subjects factor in the GLMRM model. For stepping threshold, step-
ping responses, and initial posture, the factors included in the model
were session and group. Significant interactions were explored further
using Tukey’s honestly significant difference post hoc test. Pearson’s
correlation coefficient was used to investigate correlations between
different impairments and between impairments and disease dura-
tion. Spearman’s rank correlation was used to investigate the
relationship between the number of steps induced by backward
perturbations and the UPDRS clinical pull test item score. Alpha
was set at 0.05 for significance. Unless otherwise stated, results are
means  SE.
RESULTS
The mean part III UPDRS score significantly improved with
levodopa, from 37.9 (11.7 SD) when OFF to 26.4 (9.4 SD)
when ON (P  0.001).
Initial Posture
We were unable to detect significant group differences or
effects of medication on initial body posture measured during
the period immediately preceding each pull. Four independent
variables were measured: 1) anterior position of CoP relative to
ankle joint center [PD vs. control: 61.5 3.2 vs. 56.2 2.5 mm;
F(1,30) 0.89, P 0.354], 2) ankle flexion angle [72.3 0.8 vs.
70.7 0.7 deg, F(1,30) 2.08, P 0.160], 3) hip flexion angle
[12.3 3.9 vs.0.11 2.6 deg, F(1,30) 3.61, P 0.067], and
4) torso sagittal plane angle [19.6  0.2 vs. 19.4  0.2 deg,
F(1,30)  0.43, P  0.515]. These quantities did not change
significantly with levodopa.
In-Place Responses
Figure 2A shows each group’s mean in-place responses for
backward 10-N pulls, which typified the general behavior.
Shortly after pull onset, the body initially swayed in the
direction of the pull and then was arrested or reversed while the
pull force was maintained at a constant level. This was
achieved by the generation of an opposing horizontal ground
reaction force that was initiated after a latent period of around
150 ms. In general, PD patients and control participants be-
haved similarly except that patients exerted a smaller resisting
force and consequently swayed further. This behavior in re-
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sponse to two force levels over two sessions is quantified and
analyzed in detail in the following sections. However, it should
be noted that with 20-N pulls in session 1, but not session 2,
one patient (PTP05) always stepped in the backward direction,
whereas another (PTP13) always stepped in the forward direc-
tion. This resulted in missing data for the resisting force and
CoM displacement measurements, which automatically ex-
cluded these patients’ contribution to the overall repeated-
measures analysis in one direction each.
Resisting force. On average, PD patients exerted a lower
resisting force (measured over the initial 0.5 s of pull; Fig. 2B)
compared with controls [group: backward, F(1,29) 17.15, P
0.001; forward, F(1,29)  5.15, P  0.031]. The resisting
force was lower for 10- compared with 20-N pulls [size:
backward, F(1,29)  365.95, P  0.001; forward, F(1,29) 
643.94, P  0.001]. There was not a significant main effect of
session for either direction.
Some significant interactions were present. The two groups
responded differently to the two sizes of pull, but only in the
forward pull direction [group  size: forward, F(1,29)  5.50,
P  0.026]. Post hoc comparisons showed that this stemmed
from there being a significant difference between PD and
controls for the 20-N pulls (P  0.017) that was larger
compared with the 10-N pulls, with the latter failing to produce
a significant difference between groups (P  0.812). In both
directions, there was an interaction between the size of the pull
and the session [size  session: backward, F(1,29)  9.59,
P  0.004; forward, F(1,29)  11.37, P  0.002], indicating
that for 20-N pulls, a higher force was produced in session 2
compared with session 1, and vice versa for 10-N pulls.
CoM displacement. Body sway produced by the pull was
measured from changes in CoM position (Fig. 2C). The main
effects mirrored those of the force response. Patients swayed
more than controls for both directions of pull [group: backward,
F(1,29) 8.58, P 0.007; forward, F(1,29) 5.71, P 0.024].
Both groups swayed more for 20- than for 10-N pulls [size:
backward, F(1,29)  44.76, P  0.001; forward, F(1,29) 
33.86, P  0.001]. There was not a significant main effect of
session for either direction.
The interactions were in line with those of the force re-
sponse. Thus the difference between the two groups depended
on the pull size, but only in the forward direction, with the
difference being greater at the higher pull force [group  size:
forward, F(1,29)  4.49, P  0.043]. Also, in the forward
direction (with a trend in the backward direction) there was
greater overall increase in CoM sway in session 2 relative to
session 1 for 10-N pulls compared with 20-N pulls [size 
session: backward F(1,29)  3.92, P  0.057; forward,
F(1,29)  8.91, P  0.006].
Joint moments. Ankle, knee, and hip moments, normalized
by pull force and combined for the two pull levels, are shown
in Fig. 3. These data have also been collapsed across the two
sessions because there were no significant effects of session for
either direction. The moments varied with joint type in both
directions [joint: backward, F(2,60)  350.43, P  0.001;
forward, F(2,60)  564.40, P  0.001], and the PD group
produced smaller joint moments than controls in both direc-
tions [group: backward, F(1,30)  18.248, P  0.001; for-
ward, F(1,30)  7.98, P  0.008]. For backward pulls only,
there was an interaction between group and joint indicating that
the difference between the two groups varied according to the
joint [group  joint: backward, F(2,60)  7.22, P  0.002].
The largest difference was observed for the knee extension
moment, which in PD was 75% of control values.
Stepping Threshold
In the forward direction (Fig. 4B), PD patients’ stepping
threshold was consistently lower than that of controls [group:
forward, F(1,30)  4.97, P  0.033]. In the backward direc-
tion (Fig. 4B), the only effect was an interaction [group 
session: backward, F(1,30)  5.90, P  0.021]. This reflected
Fig. 2. Whole body in-place responses. A: group mean (n  16) responses for
PD (black lines) and controls (gray lines) to 10-N pulls in the backward
direction for session 1 (PD OFF; dashed lines) and session 2 (PD ON; solid
lines). Top, perturbation force; middle, center of mass (CoM) displacement
normalized by body mass; bottom, anteroposterior (AP) ground reaction force.
B: group mean (SE) AP reaction force measured between 0 and 500 ms after
pull onset for PD (squares, black lines) and controls (circles, gray lines). Data
from force levels of 10 N (open symbols) and 20 N (filled symbols) are shown
separately for each session (S1, OFF; S2, ON) and each direction (backward,
forward). C: same conventions as B for the mean normalized CoM displace-
ment measured at the end of perturbation.
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a relative increase in threshold on the second session for PD
patients compared with controls and hints at an effect of
levodopa. However, post hoc comparisons showed that PD
patients did not differ from controls in session 1 (P  0.926)
or in session 2 (P  0.747), and PD threshold did not change
significantly with levodopa (P  0.060).
Stepping Responses
Figure 5A illustrates contrasting stepping behavior of a
representative PD patient and a control participant to a suprath-
reshold backward pull. These single trials were chosen because
they had the same level and direction of pull and produced very
similar initial CoM trajectories and latencies of first foot lift.
However, stepping execution differed because the PD partici-
pant took smaller and more steps than the control.
Step length. Mean PD step length was smaller than that of
controls (Fig. 5B), but only in the backward direction [group:
backward, F(1,30)  6.07, P  0.020]. There was neither a
main effect of session nor an interaction, indicating a lack of
effect of levodopa on step length.
Number of steps. In the backward direction (Fig. 5C), PD
patients took more steps than controls [group: backward,
F(1,30) 4.28, P 0.047], whereas fewer steps were taken in
session 2 than session 1 for both groups [session: backward,
F(1,30) 8.99, P 0.005]. In the forward direction (Fig. 5C),
there was only an interaction present, suggesting a possible
effect of levodopa on number of steps taken [group  session:
forward, F(1,30)  4.89, P  0.035]. However, post hoc
comparisons showed no difference between PD OFF compared
with controls in session 1 (P  0.197) and no significant effect
of levodopa in PD (P  0.064).
Initial conditions. Differences in step execution between
groups could not readily be explained by differences in pull
forces or in behavior at the point of step initiation. Stepping-
trial pull force did not differ between groups (PD vs. control:
backward: session 1, 29.4  2.0 vs. 29.8  1.8 N; session 2,
31.4 2.3 vs. 32.4 1.2 N; forward: session 1, 34.0 2.5 vs.
37.2 1.5 N; session 2, 37.2 2.3 vs. 39.5 1.8 N), although
the pull forces were higher in session 2 [session: F(1,30) 
15.90, P 0.001]. There were no significant group differences
for foot-lift latency (PD vs. control: backward, 0.96  0.04 vs.
0.93 0.04 s; forward, 1.03 0.03 vs. 1.12 0.05 s) or body
momentum at foot lift (PD vs. control: backward, 13.6  0.9
vs. 13.9  0.9 kg·m/s; forward, 21.5  1.4 vs. 24.3  1.5
kg·m/s). There were no effects of session for these measures.
Correlations
In the PD group there was a negative correlation between
step length and number of steps (OFF, R  0.626, P 
0.009; ON, R0.587, P 0.017) in the backward direction,
suggesting that the small step length was functionally inade-
quate. In the OFF or ON state, the severity of the two main PD
Fig. 4. Stepping threshold. A: example of sigmoid curve using all trials
collected in one session from a representative participant for calculation of
stepping threshold (before normalization). B: group mean (SE) stepping
threshold normalized by body mass in each session (S1, OFF; S2, ON) for PD
(black squares) and controls (gray circles) shown separately for backward
(solid lines) and forward (dashed lines) pulls.
Fig. 3. In-place joint moments. Combined left and right joint moments in the
sagittal plane were measured between 0 and 500 ms after pull onset. Moments
were normalized by pull force and averaged across 10- and 20-N pulls and
across sessions. Group means (SE) are shown separately for backward (left)
and forward (right) perturbations in PD (squares, black lines) and controls
(circles, gray lines). Direction of moments is shown as dorsiflexion (DF) or
plantarflexion (PF) for ankle and extension (E) or flexion (F) for knee and hip.
498 BALANCE IN PARKINSON’S DISEASE
J Neurophysiol • doi:10.1152/jn.00996.2015 • www.jn.org
 by 10.220.33.6 on Septem
ber 20, 2016
http://jn.physiology.org/
D
ow
nloaded from
 
deficits, i.e., decreased in-place resisting force and decreased
step length, did not correlate with each other in either direction.
Disease duration did not correlate with the severity of either
deficit. The number of steps induced by backward perturba-
tions correlated with the clinical pull test UPDRS score when
ON (Spearman’s   0.721, P  0.002), but not when OFF
(Spearman’s  0.025, P  0.926).
DISCUSSION
In this study we measured balance responses to external
forces applied to the torso at the level of the shoulders. To our
knowledge, controlled shoulder perturbations delivered by mo-
tors have not previously been used in this way to study PD
balance deficits, even though manual pulls to the shoulders are
routinely used in clinical practice as a test component of the
UPDRS. We believe, also, that this study is the first to analyze
in the same PD patients the impairments of both in-place and
stepping responses, together with the levodopa responsiveness
of those impairments, using one perturbation method. The
majority of previous laboratory-based studies of PD balance
control have employed platform perturbations that either trans-
late the feet or rotate the ankles to destabilize the body, some
of which have measured in-place responses and others stepping
responses (see Introduction for references). Although we refer
to the results of these studies when they are relevant to the
discussion, a direct comparison between responses to platform
perturbations and shoulder pulls has limitations because of the
different sensory inputs evoked by the two types of stimuli.
The different sites of force application give rise to different
cutaneous and proprioceptive patterns of input, while pertur-
bations at the level of the floor compared with shoulder
generally will lead to different head-in-space trajectories, and
hence different vestibular and visual inputs.
The results of the current study revealed differences between
PD patients and healthy participants for both the in-place and
stepping responses used to maintain balance. This was despite
the limitation that we studied patients who were only moder-
ately affected by the disease (Hoehn and Yahr stage 2–3).
Before discussing the possible involvement of dopaminergic
pathways, we first address the question as to whether these
differences represent true impairments of the underlying mech-
anisms.
Is the In-Place Balance Mechanism Impaired in PD?
When relatively small forces were used to perturb the body
(10 and 20 N), the PD in-place responses were smaller than
control responses, leading to increased displacements of the
body in the direction of the pull, consistent with results from
some platform perturbation studies (Bloem et al. 1996; Car-
penter et al. 2004; Dimitrova et al. 2004; Oude Nijhuis et al.
2014). However, we cannot immediately conclude that the
reduced PD response was caused by an impaired mechanism.
Most PD patients were able to maintain sufficient resistive
force throughout these perturbations to prevent a step. Argu-
ably, therefore, their response was adequate for this specific
task. On the other hand, two patients always stepped with 20-N
pulls (one in the backward and the other in the forward
direction), suggesting that their in-place responses were func-
tionally inadequate. A similar deficit became apparent for the
PD group as a whole when we increased the pull force to
determine the threshold level required to evoke a step. These
data showed that PD patients had a lower threshold for steps
when being pulled forward, thus favoring an impairment of the
in-place balance mechanism.
Against this interpretation was the apparent lack of differ-
ence between PD and control thresholds for backward pulls,
even though PD in-place responses were reduced in this direc-
tion also. The reason behind the threshold discrepancy in the
two directions is unclear. One possibility is that the muscles
that resist forward pulls (ankle plantarflexors and hip exten-
sors) are relatively weaker than the muscles that resist back-
Fig. 5. Stepping responses. A: representative PD and control participants for
29-N backward pull. Top, perturbation force (solid black lines); bottom, AP
position of CoM (dashed black), and heels (R, right, solid dark gray lines; L,
left, solid light gray lines). Although the pulls were identical and the body
displacement (CoM trajectory) and foot-lift time were similar, the PD patient
took multiple short steps, whereas the control participant took a single longer
step. B: group mean (SE) length of first step for PD patients (squares, black
lines) and controls (circles, gray lines) for each session (S1, OFF; S2, ON) in
the backward (left) and forward (right) directions. C: same conventions as B
for group mean (SE) number of steps taken per trial.
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ward pulls (ankle dorsiflexors and hip flexors). However, this
was not apparent in the joint moments measured during 10- and
20-N pulls. If anything, the moments were larger and closer to
control values for the forward pulls (see Fig. 3). This is
consistent with the finding that although PD ankle muscles are
weaker than those of healthy subjects, plantarflexors are rela-
tively less affected than dorsiflexors during eccentric contrac-
tions (Pang and Mak 2012). Another possible explanation may
be found in the process that drives the decision to take a step
when being perturbed by external forces. It has been shown
that this decision is not determined simply by the body’s
mechanical state induced by the external force; contextual
factors also play a role. These can exert powerful modulatory
effects and lead to steps being taken when they are not strictly
necessary (Pai et al. 1998) or delay their onset latency when
they are (Rogers et al. 2003). In the current study there may
have been greater pressure for the PD patients not to take a step
specifically when pulled backward, since step execution in that
direction is deficient (see below). Awareness of this deficiency
could have elevated the PD backward-stepping threshold com-
pared with their forward threshold.
Overall, the abnormally low in-place responses in both
directions together with abnormally low stepping threshold,
albeit in one direction, point to impairment of the balance
mechanism due to the pathophysiology of PD. The impairment
did not appear to be related to response saturation. Thus, when
perturbed with 20-N pulls, PD patients produced responses
almost twice as large as with 10-N pulls, and larger than the
controls’ 10-N responses. In other words, PD patients were
able to generate the normal resistive force magnitude but for
some reason failed to do so. This could mean that the gain of
the balance response was set abnormally low in PD. This is an
attractive idea that has been postulated to explain other PD
motor problems (DeLong 1990; Filion et al. 1988; Konczak et
al. 2009). If the gain of the response were lower than normal,
one would expect the relationship between response output and
stimulus input to have a smaller slope for PD compared with
controls. Although caution is required because only two points
within the total input-output curve have been measured, our
data shown in Fig. 2 support this idea for pulls in the forward
direction (reflected in the group  size interaction), but not in
the backward direction.
In the backward direction, the slopes, hence gains, appear
similar for PD patients and controls. The PD curves give the
appearance of being offset below the control curves, as if a fixed
part of the input signal had not been processed. This could occur
if there was excessive noise somewhere within the sensorimotor
loops engaged by the task. In this case the signals would have to
exceed the noise band before they could be detected and a
response issued. Thus an elevated noise band would require a
larger input to produce a given output, leading to the apparent
offset input-output relationship without a change in slope seen
here. This suggestion is consistent with reports of elevated noise
levels caused by loss of selective firing of globus pallidus neurons
in animal models of PD (Filion et al. 1988; Konczak et al. 2009).
Is the Balance-Recovery Stepping Mechanism Impaired in PD?
When higher (suprathreshold) force levels were applied,
balance could no longer be maintained by in-place responses
and so balance-recovery steps had to be executed as a second
line of defense. The balance-recovery steps when measured as
foot displacement relative to hip were abnormally small in PD
patients, but this was evident only in the backward direction.
The same result was obtained when absolute foot displace-
ments were measured (data not shown), although others have
failed to find abnormally small steps to a backward perturba-
tion (de Kam et al. 2014; Lee et al. 2013; McVey et al. 2013;
Smulders et al. 2014). There was an inverse correlation
between step length and number of steps backward, indicat-
ing that the step was functionally inadequate because it was
less successful in stopping the body. This suggests that the
mechanism driving the initial backward step is indeed im-
paired in PD.
We were unable to find a similar impairment for stepping in
the forward direction, in contrast to results from platform
translation studies (de Kam et al. 2014; Jacobs and Horak
2006; King et al. 2010; Lee et al. 2013). Does this reflect a true
directional difference, or might it be an experimental artifact?
One area of concern is that different force levels were em-
ployed to evoke steps in the two directions, with that of
forward pulls being greater on average than backward pulls.
There was no consistent difference in pull magnitude between
groups, but the stepping threshold in the forward direction was
lower for PD patients than controls. However, this would mean
that the forward pull levels were relatively more destabilizing
for PD patients. If the PD group had an underlying impairment
for stepping in the forward direction, one might expect this bias
to exacerbate rather than diminish step execution deficits. This
leads us to favor the interpretation that there are true directional
differences in PD stepping responses, with recovery steps in
the backward direction being more impaired than those in the
forward direction.
Are PD Balance Impairments Dopamine Dependent?
Although the balance mechanisms responsible for the in-
place response and the stepping response both showed impair-
ments in PD patients, we were unable to find a correlation
between the severities of their respective deficits. This may
indicate that the two balance mechanisms to some extent utilize
separate neural structures. To investigate the influence of
dopaminergic pathways on these mechanisms, we measured
the extent to which the two deficits were reduced by adminis-
tration of levodopa. To establish an effect of levodopa, there
had to be a significant improvement in PD performance be-
tween session 2 when ON and session 1 when OFF, and the
improvement had to be significantly greater than that of the
control group across their two sessions. For both balance
mechanisms we were unable to find a convincing improvement
of performance through levodopa administration.
This lack of an effect of levodopa on balance deficits is
consistent with previous studies (Bejjani et al. 2000; Bloem et
al. 1998; Carpenter et al. 2004; de Kam et al. 2014; Foreman
et al. 2012; Guehl et al. 2006; Horak et al. 1996; King et al.
2010; Jacobs and Horak 2006; Rocchi et al. 2002) and could be
taken to mean that the deficits are caused by nondopaminergic
mechanisms. However, because of the observed trends for
increase in backward step threshold and decrease in number of
forward steps with levodopa, we cannot rule out the possibility
that dopaminergic mechanisms also are involved. If multiple
lesions were responsible for the balance impairments, treating
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one lesion would not necessarily restore function. Therefore,
we can reasonably conclude that nondopaminergic lesions play
an important role in PD balance impairments (Bohnen et al.
2009; Muller et al. 2013), but dopaminergic lesions may
contribute to the process. This would be consistent with the
progressive worsening of balance problems and the emergence
of nondopaminergic lesions as PD evolves (Bonnet et al.
1987). Cell loss in the pedunculopontine nucleus (PPN) has
been shown in PD (Hirsch et al. 1987; Rinne et al. 2008), as
well as in other diseases that cause postural abnormalities, such
as progressive supranuclear palsy (Bohnen et al. 2009; Zweigh
et al. 1989) and multiple system atrophy (Benarroch 2013).
Lesions of the PPN elicit PD-like symptoms (Pahapill and
Lozano 2000), and a relationship between loss of cholinergic
neurons in PPN and severity of PD symptoms has been
reported (Zweig et al. 1989). Thus cholinergic neurons in the
PPN that are involved in PD progression are good candidates
for a role in the balance impairments pinpointed in this study.
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